Compare Apple Inc (AAPL) vs Viatris Inc (VTRS) Price & Performance

Apple IncTrade

Viatris IncTrade

Price performance (Past 24H)

Key statistics

Apple Inc vs Viatris Inc — how do they compare? Apple Inc trades at $304.76 (market cap $4.45T), while Viatris Inc trades at $16.28 (market cap $18.69B). The key difference: Apple Inc is far larger — about 238.1× Viatris Inc's market cap, and Viatris Inc pays the higher dividend (2.95%). Which is the better fit depends on your goals.

	AAPL	VTRS
Market Cap	$4.45T	$18.69B
Volume	100,358,844	—
Sector	Technology	Health
52-Week High	$340.08	$17.86
52-Week Low	$224.90	$9.49
Enterprise Value	$4.47T	$30.80B
Dividend Yield	0.35%	2.95%

View details →View details →

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Apple Inc

AAPL trades at $308.26, down 1.62% on the day, with a bearish technical signal and support near $306. The company reported strong earnings beats in recent quarters, with Q3 2026 EPS expected at $1.98. Revenue grew to $416.16B in 2025, and net income margin improved to 27.62%. Recent news highlights AI potential through a partnership with Alphabet's Gemini, but store closures and union disputes pose headwinds.

Outlook remains positive with a consensus price target of $337.63, implying 9.5% upside, supported by robust cash flow and a 63.6% buy rating from analysts. Risks include weaker iPhone sales, regulatory fines, and competitive pressures in AI. The stock offers growth potential but requires monitoring of execution risks and macroeconomic trends.

Viatris Inc

No Aura AI signal available yet.

Aura AI is an analytical signal, not financial advice — do your own research.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

AAPL

Jefferies downgrades Apple citing costs and iPhone delays, but strong earnings and growth challenge the call.24/7 Wall Street · 18 hours agoBullish Fidelity Dividend ETF's payout is safe but not ideal for steady income due to variable quarterly dividends.24/7 Wall Street · 21 hours agoNeutral iPhone memory costs surge, pushing prices higher and squeezing margins through 202724/7 Wall Street · 22 hours agoNeutral View details →

VTRS

View details →

About Apple Inc

Apple Inc. designs, manufactures, and markets personal computers and related personal computing and mobile communication devices along with a variety of related software, services, peripherals, and networking solutions. Apple sells its products worldwide through its online stores, its retail stores, its direct sales force, third-party wholesalers, and resellers.

About Viatris Inc

Formed by the combination of Mylan and Pfizer's Upjohn business in 2020, Viatris is one of the world's largest generic drug manufacturers, with a substantial off-patent branded drug portfolio. Its portfolio consists of more than 1,400 molecules with penetration across most of the developed world and in select emerging markets. The company's branded drug portfolio consists of off-patent blockbuster drugs that continue to generate strong sales, including Lipitor, Norvasc, Lyrica, Viagra, and EpiPen. While global competition has facilitated the commodification of small-molecule generic drugs, the company has demonstrated an edge over peers in its ability to manufacture complex generics (for example, generic Advair and Copaxone).